Request for Applications
The CMCR seeks to fund primary and pilot cannabis-related studies that further enhance the understanding of the efficacy and adverse effects of cannabis and cannabinoids as pharmacological agents for the treatment of medical and psychiatric disorders, and their potential public health impacts.
Read More.
CMCR studies
Current studies examine the effects of cannabis and cannabinoids on a range of psychiatric, developmental and pain conditions, as well as the impact of use on public safety (e.g., driving). A list of current and past studies can be found here.
CMCR Symposium
Planning is currently underway for the CMCR Symposium for Spring 2022. Please check back for updates. Information on the CMCR symposium series, including archives of previous meetings, can be found here.
- All
- Announcements
- Current Studies
- Information
- News
- Presentations
- Publications
- Studies
- Symposia
- Default
- Title
- Date
- Random
-
Dr. Igor Grant presented at University of Cincinnati's Psychiatry and Behavioral Health Grand Rounds on September 8, 2021 delivering The…Read More -
David Wharton, Los Angeles Times, July 2, 2021 CMCR investigators Drs. Mark Wallace and Donald Abrams comment on marijuana as…Read More -
Elisabeth Frausto, La Jolla Light, June 25, 2021 Dr. Doris Trauner is leading a CMCR clinical trial studying the effects…Read More -
Findings show that cannabis lowers intraocular pressure significantly in adult healthy subjectsRead More -
Findings show that daily cannabis use was associated with lower inflammation in the central nervous system in people with HIVRead More
-
Jared Aarons, ABC 10 News San Diego, June 3, 2021 A study looking at cannabis as a potential treatment for…Read More -
Will Stone, KPBS, May 30, 2021 The DEA recently announced it will be issuing licenses to several manufacturers to grow…Read More -
Michelle Brubaker, UC San Diego Health Newsroom, May 19, 2021 Dr. Nathaniel Schuster is conducting the first known randomized, double-blind,…Read More -
Findings suggest CBD may be used as a strategy to alleviate the withdrawal symptoms upon nicotine cessation.Read More
-
Brooke Staggs, Orange County Register, March 19, 2021 The California Highway Patrol recently published its Impaired Driving Task Force report…Read More -
John Watson, Medscape, January 5, 2021 Dr. Mark Wallace spoke to Medscape about cannabis treatment for pain management and other…Read More -
Dr. Igor Grant presented at Penn State College of Medicine's Psychiatry and Behavioral Health Grand Rounds on January 28, 2021.…Read More -
Citing the work of the Center for Medicinal Cannabis Research, Representative Scott Peters made remarks in support of the Medical…Read More -
In November 2020, the California Bureau of Cannabis Control (BCC) announced the recipients for its public university research grants program.…Read More -
Dr. Igor Grant discusses cognitive effects of cannabis use and current cannabis research on the Navigating Neuropsychology (NavNeuro) podcast. Hosts…Read More -
Scott LaFee, UC San Diego Health Newsroom, July 14, 2020 Researchers at UC San Diego's Center for Medicinal Cannabis Research…Read More -
CMCR Director Igor Grant congratulates Donald Abrams, MD, of UCSF on his retirement, and highlights some key contributions Dr. Abrams…Read More -
Marilynn Larkin, Reuters Health, April 30, 2020 In a recently published paper, Ron Ellis and colleagues found that cannabis may…Read More -
Shalina Chatlani, KPBS, December 19, 2019 More people are buying marijuana since California legalized its retail sale two years ago.…Read More -
Alicia Wallace, CNN Business, January 2, 2020 As a growing number of states legalize cannabis, health officials are increasingly sounding…Read More
load more
hold SHIFT key to load all
load all